# The Efficacy and Safety of ALIC/NAcc-DBS for Treatment-refractory OCD

> **NCT04967560** · NA · COMPLETED · sponsor: **Shanghai Mental Health Center** · enrollment: 60 (actual)

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DEVICE:** deep brain stimulation

## Key facts

- **NCT ID:** NCT04967560
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-30
- **Primary completion:** 2023-11-13
- **Final completion:** 2024-01-29
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-05-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04967560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04967560, "The Efficacy and Safety of ALIC/NAcc-DBS for Treatment-refractory OCD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04967560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*